Re:search – The Polyphenol Frontier: How Dr. Ken Brown and KBS Research Are Advancing Nutraceutical Science through Atrantil and Re:flux
Written by Paula Owen
Expert Review By KBS Research Team
Polyphenols and Gut Health
Emerging research confirms that although only 5–10% of ingested polyphenols are absorbed in the small intestine, the majority persist into the colon, where they undergo transformation by gut microbes into bioactive metabolites[^3]. These interactions not only enhance polyphenol bioavailability but also stimulate beneficial gut bacteria while inhibiting pathogenic strains[1][3][4].
Atrantil: A Model Polyphenolic Formula
Dr. Ken Brown developed Atrantil to address Small Intestinal Bacterial Overgrowth (SIBO) and related bloating and constipation symptoms. It combines quebracho, conker tree, and peppermint extracts—rich in tannins—to target methane-producing overgrowth and promote motility[5]. A randomized, double-blind pilot study demonstrated significant symptom reduction (p < 0.001) with excellent safety profile[6].
Re:flux: Extending the Polyphenol Strategy to Reflux
Building upon Atrantil’s model, Dr. Brown and the KBS team created Re:flux to address gastroesophageal reflux. This formulation leverages polyphenols like hesperidin and Atractylodes to strengthen esophageal sphincter tone, improve motility, protect mucosa, and naturally regulate acid—offering a root-cause–oriented alternative to conventional PPIs.
The Polyphenol Paradigm in Nutraceutical Innovation
Dr. Brown’s work represents a breakthrough in systems-based nutraceutical design, emphasizing:
- Multi-targeted action (e.g., microbial modulation, motility, mucosal protection)
- Respect for natural physiology rather than suppression
- Combining clinical insight with botanical science
- This philosophy represents a shift from isolated molecule-based supplements toward integrative, functional medicine-based formulations.
Conclusion
Polyphenols hold powerful potential for digestive health through their holistic and multi-modal properties. Dr. Ken Brown’s formulations—Atrantil and Re:flux—embody this potential, advancing the field of nutraceuticals by addressing root causes of GI discomfort rather than masking symptoms. As consumer and clinical demand grows for safer and more effective digestive solutions, polyphenol-based strategies could reshape future care paradigms.